Sustainable Development Goals
The Sustainable Development Goals (SDGs) are a call to action to end poverty, protect the planet, and ensure that all people enjoy peace and prosperity. BIO contributes to inclusive and sustainable economic growth by integrating the Goals in its decision-making processes and strategy.
Due to its specific mandate, BIO contributes to private sector growth, inclusiveness, and attention to the environment as core values and desired outcomes resulting from its interventions. This translates directly to SDG5 and SDG10 (inclusiveness), SDG8 and SDG9 (private sector), and SDG7 and SDG12 (environment). These SDGs are integrated in the assessment, monitoring, and evaluation of BIO’s investment projects.
More transversally, BIO contributes to the other SDGs, for example by investing in the agri-value chain (SDG2) or by steering its projects towards reducing GHG emissions (SDG13). Overall, BIO collaborates and cooperates with its clients, and organisations like Enabel, DGD, or EDFI to strengthen the collective effort towards the achievement of the goals (SDG17). This report highlights the six SDGs to which BIO directly contributes.
Data disclaimer
BIO continuously aims to improve its data collection and reporting on the development effectiveness of its investments.
At the moment, BIO relies on its clients to report on a selected number of indicators using a standardised template. There is a one-year lag due to the time required for clients to collect this information, and for BIO to verify, consolidate and analyse it.
Most figures are based on data reported by project companies and aggregated on a portfolio level. These figures capture the entire activity and development effect of the company and do not take BIO’s investment share into account.
This publication is based on the 106 reports submitted by clients (out of 123 expected). Another 24 projects are:
- in distress: These projects are facing significant challenges that may prevent them from completing comprehensive reports.
- exempt: Certain projects, like those in the very early stages of development, may be temporarily exempt from reporting requirements. Such exemptions are granted on a case-by-case basis, considering factors such as the project's stage of development and the burden of reporting. This ensures a balance between collecting valuable data and avoiding excessive administrative tasks for BIO’s clients.
In 2023, BIO approved 21 new investments, for a total of EUR 204 M. In all projects BIO will be financially additional, and for 19 of them BIO will be non-financially additional through the reinforcement of ESG risk management strategies and policies of the investee companies, most commonly with the support of the Business Development Support Fund.